RARE 44.22 (+1.73%)
US90400D1081BiotechnologyBiotechnology

Ultragenyx Pharmaceutical (RARE) Competitor Comparison

We are evaluating the key criteria listed to compare Ultragenyx Pharmaceutical (RARE) against its competitors in the Biotechnology industry.

Gross Profits - RARE ranking 274 / 278

These are the competitors of Ultragenyx Pharmaceutical in the industry Biotechnology ranked by gross profits
1. Moderna MRNA
10.55B
2. ImmuCell ICCC
7.65B
3. Regeneron Pharmaceuticals REGN
7.02B
4. Vertex Pharmaceuticals VRTX
5.32B
5. Jazz Pharmaceuticals JAZZ
3.39B
6. United Therapeutics UTHR
1.78B
7. Biomarin Pharmaceutical BMRN
1.61B
8. Incyte INCY
1.59B
9. Exelixis EXEL
1.55B
10. Royalty Pharma RPRX
1.33B
11. Vir Biotechnology VIR
1.03B
12. Neurocrine Biosciences NBIX
1B
13. Alkermes ALKS
893.69M
14. Alnylam Pharmaceuticals ALNY
868.6M
15. Bio-Techne TECH
770.22M
16. Maravai LifeSciences Holdings MRVI
714.04M
17. Halozyme Therapeutics HALO
454.21M
18. Dynavax Technologies DVAX
448.22M
19. Corcept Therapeutics CORT
396.47M
20. Harmony Biosciences Holdings HRMY
354.37M
21. AbCellera Biologics ABCL
311.11M
22. Amicus Therapeutics FOLD
290.63M
23. Intercept Pharmaceuticals ICPT
284.73M
24. Innoviva INVA
276.11M
25. Ginkgo Bioworks Holdings DNA
273.49M
26. ITeos Therapeutics ITOS
267.63M
27. Arrowhead Pharmaceuticals ARWR
240.74M
28. Vanda Pharmaceuticals VNDA
230.1M
29. Seagen SGEN
207.99M
30. Certara CERT
203.07M
31. Veracyte VCYT
194.95M
32. Global Blood Therapeutics GBT
191.43M
33. Insmed INSM
190.23M
34. Pharming Group PHAR
188.06M
35. Blueprint Medicines BPMC
177.28M
36. Kiniksa Pharmaceuticals KNSA
173.21M
37. Puma Biotechnology PBYI
172.94M
38. Catalyst Pharmaceuticals CPRX
160.02M
39. Karyopharm Therapeutics KPTI
151.86M
40. ACADIA Pharmaceuticals ACAD
145.49M
41. Akebia Therapeutics AKBA
140.04M
42. Arvinas ARVN
131.4M
43. Vericel VCEL
109.79M
44. Ligand Pharmaceuticals LGND
107.34M
45. Paratek Pharmaceuticals PRTK
99.39M
46. Anika Therapeutics ANIK
96.78M
47. Intra-Cellular Therapies ITCI
95.16M
48. Cerus CERS
87.09M
49. Enanta Pharmaceuticals ENTA
86.16M
50. Lyell Immunopharma LYEL
84.68M
51. Aurinia Pharmaceuticals AUPH
83.38M
52. SIGA Technologies SIGA
77.82M
53. BridgeBio Pharma BBIO
74.21M
54. Myovant Sciences MYOV
72.02M
55. Apellis Pharmaceuticals APLS
69.79M
56. Aytu BioPharma AYTU
66.63M
57. Mirum Pharmaceuticals MIRM
64.69M
58. Arcturus Therapeutics Holdings ARCT
62.95M
59. Y-mAbs Therapeutics YMAB
57.7M
60. UroGen Pharma URGN
56.7M
61. Berkeley Lights BLI
53.78M
62. Rigel Pharmaceuticals RIGL
53.72M
63. CytomX Therapeutics CTMX
53.16M
64. CTI BioPharma CTIC
50.43M
65. G1 Therapeutics GTHX
47.55M
66. Axsome Therapeutics AXSM
45.94M
67. ChromaDex CDXC
42.8M
68. MannKind MNKD
42.27M
69. Albireo Pharma ALBO
39.22M
70. ADMA Biologics ADMA
35.27M
71. ADC Therapeutics ADCT
35.1M
72. Avid Bioservices CDMO
31.48M
73. Turning Point Therapeutics TPTX
30.83M
74. Aquestive Therapeutics AQST
28.29M
75. Protalix BioTherapeutics PBDA.F
28.05M
76. VectivBio Holding VECT
27.34M
77. Jounce Therapeutics JNCE
27.2M
78. EyePoint Pharmaceuticals EYPT
26.95M
79. KemPharm KMPH
26.59M
80. Protagonist Therapeutics PTGX
26.58M
81. Precision BioSciences DTIL
25.1M
82. Adicet Bio ACET
24.99M
83. Champions Oncology CSBR
24.34M
84. Cellectis CLLS
23.95M
85. Rhythm Pharmaceuticals RYTM
21.51M
86. F-star Therapeutics FSTX
21.17M
87. Precigen PGEN
20.57M
88. Codexis CDXS
20.46M
89. MeiraGTx Holdings MGTX
15.92M
90. Equillium EQ
15.76M
91. Ardelyx ARDX
15.54M
92. Repare Therapeutics RPTX
15.11M
93. Eton Pharmaceuticals ETON
14.32M
94. MediWound MDWD
13.17M
95. Liquidia LQDA
13.08M
96. Agios Pharmaceuticals AGIO
12.54M
97. Stoke Therapeutics STOK
12.41M
98. Eiger BioPharmaceuticals EIGR
11.65M
99. BioCryst Pharmaceuticals BCRX
10.94M
100. Karuna Therapeutics KRTX
10.64M
101. Pliant Therapeutics PLRX
9.69M
102. Spectrum Pharmaceuticals SPPI
8.32M
103. Verrica Pharmaceuticals VRCA
8.31M
104. Ambrx Biopharma AMAM
7.4M
105. Seer SEER
7.09M
106. BioStem Technologies BSEM
5.99M
107. XOMA XOMA
5.87M
108. Organicell Regenerative Medicine OCEL
5.74M
109. Comp SBS
5.32M
110. Milestone Pharmaceuticals MIST
5M
111. XBiotech XBIT
3.36M
112. Arcutis Biotherapeutics ARQT
2.93M
113. Oramed Pharmaceuticals ORMP
2.7M
114. PTC Therapeutics PTCT
2.63M
115. Verastem VSTM
2.6M
116. TG Therapeutics TGTX
2.52M
117. Taysha Gene Therapies TSHA
2.5M
118. Capricor Therapeutics CAPR
1.75M
119. Bolt Biotherapeutics BOLT
1.62M
120. RAPT Therapeutics RAPT
1.53M
121. Lumos Pharma LUMO
1.52M
122. Ovid Therapeutics OVID
1.5M
123. Fennec Pharmaceuticals FENC
1.45M
124. Relay Therapeutics RLAY
1.38M
125. Kala Pharmaceuticals KALA
1.33M
126. Cue Biopharma CUE
1.25M
127. Cyclo Therapeutics CYTH
1.23M
128. Synlogic SYBX
1.18M
129. Clearside Biomedical CLSD
1.12M
130. IGM Biosciences IGMS
1.07M
131. SciSparc SPRC
1.03M
132. Dyadic DYAI
807.11K
133. Nutriband NTRB
750.41K
134. Lipocine LPCN
500K
135. VYNE Therapeutics VYNE
477K
136. INmune Bio INMB
374K
137. BioXcel Therapeutics BTAI
355K
138. Rafael Holdings RFL
279K
139. Allogene Therapeutics ALLO
243K
140. ImmunityBio IBRX
240K
141. Regen BioPharma RGBPP
235.52K
142. ATAI Life Sciences ATAI
233K
143. Opthea OPT
218.45K
144. Polydex Pharmaceuticals POLXF
211.62K
145. BioRestorative Therapies BRTX
119.8K
146. Verona Pharma VRNA
112K
147. GlycoMimetics GLYC
75K
148. Benitec Biopharma BNTC
75K
149. Cormedix CRMD
61.67K
150. Entera Bio ENTX
33K
151. BELLUS Health BLU
16K
152. Arch Therapeutics ARTH
-35.84K
153. VistaGen Therapeutics VTGN
-227.3K
154. Aeglea BioTherapeutics AGLE
-262K
155. Celularity CELU
-1.69M
156. Ocular Therapeutix OCUL
-6.51M
157. Gain Therapeutics GANX
-7.66M
158. Idera Pharmaceuticals IDRA
-9.25M
159. Plus Therapeutics PSTV
-9.47M
160. vTv Therapeutics VTVT
-9.93M
161. Liminal Biosciences LMNL
-10.89M
162. Theravance Biopharma TBPH
-12.05M
163. SAB Biotherapeutics SABS
-12.53M
164. Adaptive Biotechnologies ADPT
-13.66M
165. Vaccinex VCNX
-13.7M
166. Angion Biomedica ANGN
-15.8M
167. ProMIS Neurosciences PMN
-16.09M
168. Corbus Pharmaceuticals Holdings CRBP
-16.14M
169. Tarsus Pharmaceuticals TARS
-17.76M
170. Aadi Bioscience AADI
-18.78M
171. eFFECTOR Therapeutics EFTR
-19.76M
172. Voyager Therapeutics VYGR
-19.86M
173. Revance Therapeutics RVNC
-20.39M
174. Candel Therapeutics CADL
-20.66M
175. Poseida Therapeutics PSTX
-22.41M
176. Sigilon Therapeutics SGTX
-24.69M
177. Cardiff Oncology CRDF
-26.72M
178. Morphic Holding MORF
-31.25M
179. Travere Therapeutics TVTX
-31.35M
180. Oncternal Therapeutics ONCT
-31.49M
181. Acumen Pharmaceuticals ABOS
-32.36M
182. aTyr Pharma LIFE
-32.42M
183. Lyra Therapeutics LYRA
-34.23M
184. Xencor XNCR
-34.98M
185. Surface Oncology SURF
-37M
186. Werewolf Therapeutics HOWL
-37.36M
187. IDEAYA Biosciences IDYA
-38.61M
188. Alpine Immune Sciences ALPN
-40.18M
189. CymaBay Therapeutics CBAY
-41.64M
190. Outlook Therapeutics OTLK
-42.33M
191. Janux Therapeutics JANX
-44.83M
192. Arbutus Biopharma ABUS
-45.39M
193. TScan Therapeutics TCRX
-46.28M
194. Mesoblast MESO
-47.42M
195. Design Therapeutics DSGN
-48.61M
196. Ikena Oncology IKNA
-48.7M
197. Harpoon Therapeutics HARP
-49.48M
198. Ocugen OCGN
-49.76M
199. ChemoCentryx CCXI
-51.07M
200. Lexicon Pharmaceuticals LXRX
-52.68M
201. NextCure NXTC
-54.2M
202. Marinus Pharmaceuticals MRNS
-55.94M
203. DICE Therapeutics DICE
-56.08M
204. Finch Therapeutics Group FNCH
-57.03M
205. Fusion Pharmaceuticals FUSN
-57.43M
206. Coherus BioSciences CHRS
-58.4M
207. Aclaris Therapeutics ACRS
-60.02M
208. Macrogenics MGNX
-62.47M
209. Deciphera Pharmaceuticals DCPH
-62.56M
210. Provention Bio PRVB
-63.42M
211. Bic BCYC
-67.15M
212. Cassava Sciences SAVA
-68.03M
213. Caribou Biosciences CRBU
-68.38M
214. Esperion Therapeutics ESPR
-70.42M
215. Fulcrum Therapeutics FULC
-70.44M
216. Altimmune ALT
-70.52M
217. Omega Therapeutics OMGA
-74.02M
218. Amylyx Pharmaceuticals AMLX
-74.21M
219. Alector ALEC
-76.8M
220. 4D Molecular Therapeutics FDMT
-77.12M
221. Sarepta Therapeutics SRPT
-78.07M
222. AnaptysBio ANAB
-78.51M
223. BioAtla BCAB
-79.35M
224. Celldex Therapeutics CLDX
-79.9M
225. KalVista Pharmaceuticals KALV
-80.28M
226. Tango Therapeutics TNGX
-81.05M
227. Prothena PRTA
-81.66M
228. Atea Pharmaceuticals AVIR
-81.94M
229. Shattuck Labs STTK
-82.25M
230. Foghorn Therapeutics FHTX
-86.39M
231. C4 Therapeutics CCCC
-86.75M
232. Keros Therapeutics KROS
-87.27M
233. uniQure QURE
-87.37M
234. Scholar Rock Holding SRRK
-89.85M
235. Geron GERN
-93.67M
236. Xenon Pharmaceuticals XENE
-96.33M
237. Viridian Therapeutics VRDN
-99.12M
238. Adaptimmune Therapeutics ADAP
-100.58M
239. Immunogen IMGN
-104.76M
240. Prometheus Biosciences RXDX
-106.04M
241. Merus MRUS
-107.84M
242. Inhibrx INBX
-107.99M
243. IVERIC bio ISEE
-117.01M
244. Kymera Therapeutics KYMR
-117.42M
245. Crinetics Pharmaceuticals CRNX
-125.49M
246. NGM Biopharmaceuticals NGM
-125.73M
247. Verve Therapeutics VERV
-128.15M
248. Autolus Therapeutics AUTL
-130.86M
249. Chinook Therapeutics KDNY
-135.08M
250. Avidity Biosciences RNA
-141.18M
251. Zai Lab ZLAB
-145.39M
252. Nurix Therapeutics NRIX
-145.87M
253. Cytokinetics CYTK
-146.23M
254. Mersana Therapeutics MRSN
-146.8M
255. Editas Medicine EDIT
-155.25M
256. Novavax NVAX
-156.05M
257. FibroGen FGEN
-159.21M
258. Recursion Pharmaceuticals RXRX
-164.13M
259. Reata Pharmaceuticals RETA
-167.63M
260. Arcus Biosciences RCUS
-176M
261. Inovio Pharmaceuticals INO
-177.39M
262. Regenxbio RGNX
-184.27M
263. Revolution Medicines RVMD
-217.69M
264. Fate Therapeutics FATE
-224.15M
265. bluebird bio BLUE
-247.24M
266. Denali Therapeutics DNLI
-250.27M
267. Beam Therapeutics BEAM
-250.67M
268. argenx ARGX
-251.79M
269. Ionis Pharmaceuticals IONS
-257.87M
270. HUTCHMED (China) HCM
-271.59M
271. Legend Biotech LEGN
-284.01M
272. Sage Therapeutics SAGE
-319.29M
273. Intellia Therapeutics NTLA
-367.86M
274. Ultragenyx Pharmaceutical RARE
-370.78M
275. Roivant Sciences ROIV
-477.06M
276. BeiGene BGNE
-511.06M
277. Mirati Therapeutics MRTX
-519.79M
278. CRISPR Therapeutics CRSP
-570.7M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.